Cite

HARVARD Citation

    Calip, G. et al. (2020). Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma. International journal of cancer. 147 (5), pp. 1300-1305. [Online]. 
  
Back to record